Positive correlations between liver-infiltrating IL-22+ cells and liver fibrosis stage were identified, and blockade of IL-22 significantly reduces hepatic lymphocyte recruitment and fibrosis progression by relieving the expression of CXCL10 and CCL20 in HBV Tg mice [73]. This evidence concerns the gene IL22 and Hepatic fibrosis.